{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:53:35Z","timestamp":1791928415018,"version":"4.3.4"},"reference-count":223,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LMS26H070002"],"award-info":[{"award-number":["LMS26H070002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"award":["LMS26H070002"],"award-info":[{"award-number":["LMS26H070002"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2023RC036"],"award-info":[{"award-number":["2023RC036"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100702"],"award-info":[{"award-number":["82100702"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"award":["82100702"],"award-info":[{"award-number":["82100702"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Diabetes and related metabolic disorders, including metabolic dysfunction-associated steatotic liver disease (MASLD), are increasingly recognized as diseases of inter-organ metabolic dysregulation rather than disorders of a single organ. The core of this process is the liver\u2013pancreas axis, which integrates metabolic signals to maintain glucose and lipid homeostasis. Under physiological conditions, insulin and glucagon work together to regulate glucose production in the liver. The liver, in turn, regulates pancreatic \u03b2-cell function through hepatokines, metabolites and extracellular vesicles. Axis disorder driven by liver insulin resistance, lipid accumulation, inflammation or changes in hepatokine secretion exacerbates \u03b2-cell dysfunction, glucotoxicity and lipotoxic stress, thereby accelerating disease progression. This imbalance is involved in the pathogenesis of type 2 diabetes, type 1 diabetes, gestational diabetes, and monogenic diabetes, and makes MASLD a driving factor and early predictor of diabetes onset. This review summarizes the key molecular mechanisms behind liver\u2013pancreas crosstalk and explores potential therapeutic strategies aimed at restoring coordinated metabolic regulation between the organs.<\/jats:p>","DOI":"10.3390\/biom16040613","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:42:45Z","timestamp":1776771765000},"page":"613","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Emerging Insights into the Liver\u2013Pancreas Axis: A Central Hub in the Pathogenesis of Diabetes and Metabolic Diseases"],"prefix":"10.3390","volume":"16","author":[{"given":"Hengqian","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_2","unstructured":"GBD 2021 Diabetes Collaborators (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet, 402, 203\u2013234."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: Data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries","volume":"55","author":"Letafatkar","year":"2024","journal-title":"Arch. Med. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Janic, M., Janez, A., El-Tanani, M., and Rizzo, M. (2025). Obesity: Recent Advances and Future Perspectives. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020368"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wu, H., Norton, V., Cui, K., Zhu, B., Bhattacharjee, S., Lu, Y.W., Wang, B., Shan, D., Wong, S., and Dong, Y. (2022). Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.841928"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cegh.2020.05.016","article-title":"Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers","volume":"9","author":"Hussain","year":"2021","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF diabetes atlas 11th edition 2025: Global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2337\/db23-0926","article-title":"Quantitative Imaging Reveals Steatosis and Fibroinflammation in Multiple Organs in People with Type 2 Diabetes: A Real-World Study","volume":"73","author":"Diamond","year":"2024","journal-title":"Diabetes"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100763","DOI":"10.1016\/j.xcrm.2022.100763","article-title":"Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues","volume":"3","author":"Diamanti","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Marroncini, G., Naldi, L., Martinelli, S., and Amedei, A. (2024). Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies. Biomedicines, 12.","DOI":"10.3390\/biomedicines12071398"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tao, T., Deng, P., Wang, Y., Zhang, X., Guo, Y., Chen, W., and Qin, J. (2022). Microengineered Multi-Organoid System from hiPSCs to Recapitulate Human Liver-Islet Axis in Normal and Type 2 Diabetes. Adv. Sci., 9.","DOI":"10.1002\/advs.202103495"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cmet.2021.03.007","article-title":"Direct and indirect control of hepatic glucose production by insulin","volume":"33","author":"Lewis","year":"2021","journal-title":"Cell Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1042\/BCJ20210071","article-title":"SREBP-1c and lipogenesis in the liver: An update1","volume":"478","author":"Ferre","year":"2021","journal-title":"Biochem. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1152\/physrev.00028.2023","article-title":"Hepatic glucagon action: Beyond glucose mobilization","volume":"104","author":"Kajani","year":"2024","journal-title":"Physiol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2337\/db05-1435","article-title":"Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1\/2 and Akt signaling pathways","volume":"55","author":"Wente","year":"2006","journal-title":"Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00125-021-05435-1","article-title":"The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells","volume":"64","author":"Gerst","year":"2021","journal-title":"Diabetologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/bs.ircmb.2021.02.013","article-title":"Molecular mechanisms of lipotoxicity-induced pancreatic beta-cell dysfunction","volume":"359","author":"Uribe","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref_22","unstructured":"Dinic, S., Arambasic Jovanovic, J., Uskokovic, A., Mihailovic, M., Grdovic, N., Tolic, A., Rajic, J., Dordevic, M., and Vidakovic, M. (2022). Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management. Front. Endocrinol., 13."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/endrev\/bnae032","article-title":"Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance","volume":"46","author":"Apostolopoulou","year":"2025","journal-title":"Endocr. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00125-025-06428-0","article-title":"Aetiology of type 2 diabetes: An experimental medicine odyssey","volume":"68","author":"Taylor","year":"2025","journal-title":"Diabetologia"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Szukiewicz, D. (2023). Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202305.1026.v1"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Xie, Y.P., Lin, S., Xie, B.Y., and Zhao, H.F. (2023). Recent progress in metabolic reprogramming in gestational diabetes mellitus: A review. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1284160"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","article-title":"Non-alcoholic fatty liver disease: Pathophysiological concepts and treatment options","volume":"119","author":"Grander","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Dogru, T., Kirik, A., Gurel, H., Rizvi, A.A., Rizzo, M., and Sonmez, A. (2021). The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126627"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.13435","article-title":"Insulin regulation of gluconeogenesis","volume":"1411","author":"Hatting","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2008.06.006","article-title":"Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation","volume":"8","author":"Dong","year":"2008","journal-title":"Cell Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Teaney, N.A., and Cyr, N.E. (2023). FoxO1 as a tissue-specific therapeutic target for type 2 diabetes. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1286838"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1530\/JME-15-0316","article-title":"Targeting cAMP\/PKA pathway for glycemic control and type 2 diabetes therapy","volume":"57","author":"Yang","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4093\/dmj.2019.0200","article-title":"Role of CRTC2 in Metabolic Homeostasis: Key Regulator of Whole-Body Energy Metabolism?","volume":"44","author":"Han","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: Sensors for hormonal and metabolic signals","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","article-title":"Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis","volume":"93","author":"Auwerx","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mehy.2015.10.029","article-title":"Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia","volume":"86","author":"Suppli","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1097\/MEG.0000000000002269","article-title":"Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression","volume":"33","author":"Wang","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2015.05.014","article-title":"Fetuin A promotes lipotoxicity in beta cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity","volume":"412","author":"Shen","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chekol Abebe, E., Tilahun Muche, Z., Behaile, T.M.A., Mengie Ayele, T., Mekonnen Agidew, M., Teshome Azezew, M., Abebe Zewde, E., Asmamaw Dejenie, T., and Asmamaw Mengstie, M. (2022). The structure, biosynthesis, and biological roles of fetuin-A: A review. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.945287"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12944-019-1021-8","article-title":"Fetuin-A is also an adipokine","volume":"18","author":"Jialal","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.3390\/nu5093757","article-title":"Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance","volume":"5","author":"Watanabe","year":"2013","journal-title":"Nutrients"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jemal, M., Waritu, N.C., Baylie, T., Sinamaw, D., Mengistu, E.F., Osman, E.E., Baye, G., Tegegne, B.A., Amare, G.A., and Teffera, Z.H. (2025). The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: A review. Ther. Adv. Chronic Dis., 16.","DOI":"10.1177\/20406223251389795"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3892\/br.2017.890","article-title":"Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues","volume":"6","author":"Lin","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jhep.2024.04.034","article-title":"FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond","volume":"81","author":"Harrison","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","article-title":"ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase","volume":"6","author":"Chi","year":"2017","journal-title":"Mol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00125-015-3590-z","article-title":"Angiopoietin-like protein 8 (ANGPTL8)\/betatrophin overexpression does not increase beta cell proliferation in mice","volume":"58","author":"Cox","year":"2015","journal-title":"Diabetologia"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Abu-Farha, M., Al Madhoun, A., and Abubaker, J. (2016). The Rise and the Fall of Betatrophin\/ANGPTL8 as an Inducer of beta-Cell Proliferation. J. Diabetes Res., 2016.","DOI":"10.1155\/2016\/4860595"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"154921","DOI":"10.1016\/j.metabol.2021.154921","article-title":"Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K\/Akt signaling pathway in diabetic mice","volume":"126","author":"Zhao","year":"2022","journal-title":"Metabolism"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A liver-derived secretory protein, selenoprotein P, causes insulin resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/ars.2020.8087","article-title":"Hepatokine Selenoprotein P-Mediated Reductive Stress Causes Resistance to Intracellular Signal Transduction","volume":"33","author":"Takamura","year":"2020","journal-title":"Antioxid. Redox Signal"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"E1325","DOI":"10.1210\/jc.2011-0620","article-title":"Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: Implications for insulin resistance, inflammation, and atherosclerosis","volume":"96","author":"Yang","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1074\/jbc.M113.479386","article-title":"Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)\/FoxO3a pathway in H4IIEC3 hepatocytes","volume":"289","author":"Takayama","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2337\/db12-0018","article-title":"Human \u03b2-Cell Proliferation and Intracellular Signaling","volume":"61","author":"Kulkarni","year":"2012","journal-title":"Diabetes"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2015.03.008","article-title":"Insulin receptor isoform A confers a higher proliferative capability to pancreatic beta cells enabling glucose availability and IGF-I signaling","volume":"409","author":"Escribano","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Vazquez-Borrego, M.C., Del Rio-Moreno, M., and Kineman, R.D. (2021). Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism. Cells, 10.","DOI":"10.3390\/cells10102532"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"108047","DOI":"10.1016\/j.jbc.2024.108047","article-title":"The signaling landscape of insulin-like growth factor 1","volume":"301","author":"Khan","year":"2025","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2337\/diabetes.51.4.966","article-title":"Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation","volume":"51","author":"Lingohr","year":"2002","journal-title":"Diabetes"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metabolism"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"170923","DOI":"10.1016\/j.peptides.2022.170923","article-title":"Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes","volume":"160","author":"Zhu","year":"2023","journal-title":"Peptides"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1007\/s00018-015-1982-3","article-title":"DAG tales: The multiple faces of diacylglycerol--stereochemistry, metabolism, and signaling","volume":"72","author":"Eichmann","year":"2015","journal-title":"Cell Mol. Life Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tips.2017.04.004","article-title":"Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance","volume":"38","author":"Petersen","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"117","author":"Samuel","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1128\/MCB.23.21.7794-7808.2003","article-title":"Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)\/Akt by a PKCzeta-dependent mechanism","volume":"23","author":"Powell","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1091\/mbc.e10-06-0481","article-title":"The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells","volume":"21","author":"Yang","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","article-title":"CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity","volume":"177","author":"Hammerschmidt","year":"2019","journal-title":"Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20101386","article-title":"Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 \u03b2-cells","volume":"438","author":"Coant","year":"2011","journal-title":"Biochem. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched Chain Amino Acids","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/288187a0","article-title":"L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase","volume":"288","author":"Sener","year":"1980","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1753-4887.2010.00282.x","article-title":"Leucine metabolism in regulation of insulin secretion from pancreatic beta cells","volume":"68","author":"Yang","year":"2010","journal-title":"Nutr. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"24795","DOI":"10.1074\/jbc.M112.344259","article-title":"Leucine stimulates insulin secretion via down-regulation of surface expression of adrenergic alpha2A receptor through the mTOR (mammalian target of rapamycin) pathway: Implication in new-onset diabetes in renal transplantation","volume":"287","author":"Yang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cmet.2017.11.004","article-title":"mTORC1 Signaling: A Double-Edged Sword in Diabetic beta Cells","volume":"27","author":"Ardestani","year":"2018","journal-title":"Cell Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.14496","article-title":"The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update","volume":"23","author":"Nauck","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000450981","article-title":"Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation","volume":"35","author":"Chiang","year":"2017","journal-title":"Dig. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: Molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Bing, H., and Li, Y.L. (2022). The role of bile acid metabolism in the occurrence and development of NAFLD. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.1089359"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nature01683","article-title":"Pathogen-induced systemic plant signal triggers DNA rearrangements","volume":"423","author":"Kovalchuk","year":"2003","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nat. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2010","journal-title":"Nat. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"33623","DOI":"10.1074\/jbc.M109.085084","article-title":"Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion","volume":"285","author":"Wijesekara","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1172\/JCI32490","article-title":"Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice","volume":"117","author":"Diwan","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/BC.2003.016","article-title":"Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver","volume":"384","author":"Carvalheira","year":"2003","journal-title":"Biol. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.2337\/diabetes.54.12.3410","article-title":"Inhibition of Preproinsulin Gene Expression by Leptin Induction of Suppressor of Cytokine Signaling 3 in Pancreatic \u03b2-Cells","volume":"54","author":"Laubner","year":"2005","journal-title":"Diabetes"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin","volume":"303","author":"Banerjee","year":"2004","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/db11-0100","article-title":"Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice","volume":"61","author":"Attane","year":"2012","journal-title":"Diabetes"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"31464","DOI":"10.1038\/s41598-024-83112-0","article-title":"Omentin-1 mitigates non-alcoholic fatty liver disease by preserving autophagy through AMPKalpha\/mTOR signaling pathway","volume":"14","author":"Huang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.semcancer.2024.02.001","article-title":"Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers","volume":"99","author":"Li","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Li, J., Zhang, Y., Ye, Y., Li, D., Liu, Y., Lee, E., Zhang, M., Dai, X., Zhang, X., and Wang, S. (2021). Pancreatic beta cells control glucose homeostasis via the secretion of exosomal miR-29 family. J. Extracell. Vesicles, 10.","DOI":"10.1002\/jev2.12055"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/liv.15654","article-title":"Steatotic hepatocyte-derived extracellular vesicles promote beta-cell apoptosis and diabetes via microRNA-126a-3p","volume":"43","author":"Chen","year":"2023","journal-title":"Liver Int."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00125-025-06445-z","article-title":"Effect of lipotoxic hepatocyte-derived extracellular vesicles in pancreas inflammation: Essential role of macrophage TLR4 in beta cell functionality","volume":"68","author":"Alen","year":"2025","journal-title":"Diabetologia"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"de Oliveira Dos Santos, A.R., de Oliveira Zanuso, B., Miola, V.F.B., Barbalho, S.M., Santos Bueno, P.C., Flato, U.A.P., Detregiachi, C.R.P., Buchaim, D.V., Buchaim, R.L., and Tofano, R.J. (2021). Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052639"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Ren, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H.R., and Gao, D. (2022). Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.873699"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jmcb\/mjw013","article-title":"The FGF21-adiponectin axis in controlling energy and vascular homeostasis","volume":"8","author":"Hui","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"508409","DOI":"10.1155\/2015\/508409","article-title":"Mechanisms Linking Inflammation to Insulin Resistance","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-kappaB, inflammation, and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2022.03.017","article-title":"Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis","volume":"77","author":"Beaulant","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","article-title":"Hepatokines and metabolism: Deciphering communication from the liver","volume":"44","author":"Potthoff","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Milani, I., Codini, M., Guarisco, G., Chinucci, M., Gaita, C., Leonetti, F., and Capoccia, D. (2024). Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910795"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/er.2006-0026","article-title":"The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications","volume":"28","author":"Dunning","year":"2007","journal-title":"Endocr. Rev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2015.39.1.1","article-title":"Pancreatic alpha-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block","volume":"39","author":"Moon","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2337\/db24-0958","article-title":"Hepatic PKA Mediates Liver and Pancreatic alpha-Cell Cross Talk","volume":"74","author":"Bao","year":"2025","journal-title":"Diabetes"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2337\/dbi22-0004","article-title":"The Liver-alpha-Cell Axis in Health and in Disease","volume":"71","author":"Richter","year":"2022","journal-title":"Diabetes"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Chen, X., Xiao, J., Pang, J., Chen, S., Wang, Q., and Ling, W. (2021). Pancreatic beta-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease. Nutrients, 13.","DOI":"10.3390\/nu13093139"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jgh3.12367","article-title":"Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non-alcoholic fatty liver disease patients","volume":"4","author":"Araki","year":"2020","journal-title":"JGH Open"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Lanthier, N., Lebrun, V., Molendi-Coste, O., van Rooijen, N., and Leclercq, I.A. (2022). Liver Fetuin-A at Initiation of Insulin Resistance. Metabolites, 12.","DOI":"10.3390\/metabo12111023"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2337\/db13-0645","article-title":"High glucose represses beta-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: Involvement of peroxisome proliferator-activated receptor gamma signaling","volume":"62","author":"So","year":"2013","journal-title":"Diabetes"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jcmm.14007","article-title":"Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K\/Akt signaling-dependent manner","volume":"23","author":"Pan","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"114746","DOI":"10.1016\/j.celrep.2024.114746","article-title":"Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCepsilon-insulin receptor(T1150) phosphorylation pathway","volume":"43","author":"Xu","year":"2024","journal-title":"Cell Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1007\/s00125-017-4385-1","article-title":"Metabolic crosstalk between fatty pancreas and fatty liver: Effects on local inflammation and insulin secretion","volume":"60","author":"Gerst","year":"2017","journal-title":"Diabetologia"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Park, S.J., Garcia Diaz, J., Um, E., and Hahn, Y.S. (2023). Major roles of kupffer cells and macrophages in NAFLD development. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1150118"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1152\/physiol.00048.2018","article-title":"Hepatic Insulin Clearance: Mechanism and Physiology","volume":"34","author":"Najjar","year":"2019","journal-title":"Physiology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2337\/db17-1520","article-title":"Variability of Directly Measured First-Pass Hepatic Insulin Extraction and Its Association with Insulin Sensitivity and Plasma Insulin","volume":"67","author":"Paszkiewicz","year":"2018","journal-title":"Diabetes"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"155607","DOI":"10.1016\/j.metabol.2023.155607","article-title":"Hepatic insulin receptor: New views on the mechanisms of liver disease","volume":"145","author":"Lee","year":"2023","journal-title":"Metabolism"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Tian, Y., Mehta, K., Jellinek, M.J., Sun, H., Lu, W., Shi, R., Ingram, K., Friedline, R.H., Kim, J.K., and Kemper, J.K. (2023). Hepatic Phospholipid Remodeling Modulates Insulin Sensitivity and Systemic Metabolism. Adv. Sci., 10.","DOI":"10.1002\/advs.202300416"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/db20-0635","article-title":"CEPT1-Mediated Phospholipogenesis Regulates Endothelial Cell Function and Ischemia-Induced Angiogenesis Through PPARalpha","volume":"70","author":"Zayed","year":"2021","journal-title":"Diabetes"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"104578","DOI":"10.1016\/j.jbc.2023.104578","article-title":"Differential contributions of phosphotransferases CEPT1 and CHPT1 to phosphatidylcholine homeostasis and lipid droplet biogenesis","volume":"299","author":"Dorighello","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/bph.70210","article-title":"Imperatorin ameliorates metabolic dysfunction-associated fatty liver disease through modulating Suv39h1\/Fabps\/Cept1 signalling pathway","volume":"183","author":"Sun","year":"2026","journal-title":"Br. J. Pharmacol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"Kennelly","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Casares, D., Escriba, P.V., and Rossello, C.A. (2019). Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092167"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Meijer, R.I., and Barrett, E.J. (2021). The Insulin Receptor Mediates Insulin\u2019s Early Plasma Clearance by Liver, Muscle, and Kidney. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010037"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Ortiz-Lopez, N., Madrid, A.M., Aleman, L., Zazueta, A., Smok, G., Valenzuela-Perez, L., Poniachik, J., and Beltran, C.J. (2024). Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A cross-sectional study. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1376148"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1038\/ncomms4878","article-title":"Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance","volume":"5","author":"Jia","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases","volume":"26","author":"An","year":"2022","journal-title":"J. Gastrointest. Surg."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Garay-Malpartida, H.M., Mourao, R.F., Mantovani, M., Santos, I.A., Sogayar, M.C., and Goldberg, A.C. (2011). Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis. BMC Immunol., 12.","DOI":"10.1186\/1471-2172-12-18"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Yang, M., Pan, M., Huang, D., Liu, J., Guo, Y., Liu, Y., and Zhang, W. (2023). Glucagon Promotes Gluconeogenesis through the GCGR\/PKA\/CREB\/PGC-1alpha Pathway in Hepatocytes of the Japanese Flounder Paralichthys olivaceus. Cells, 12.","DOI":"10.3390\/cells12071098"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.tem.2024.05.006","article-title":"Increased hepatic gluconeogenesis and type 2 diabetes mellitus","volume":"35","author":"Barroso","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: Is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Rafaqat, S., Gluscevic, S., Mercantepe, F., Rafaqat, S., and Klisic, A. (2024). Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease. Metabolites, 14.","DOI":"10.3390\/metabo14030153"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4093\/dmj.2020.0053","article-title":"The Role of CD36 in Type 2 Diabetes Mellitus: Beta-Cell Dysfunction and Beyond","volume":"44","author":"Moon","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Armandi, A., Rosso, C., Caviglia, G.P., and Bugianesi, E. (2021). Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites, 11.","DOI":"10.3390\/metabo11030155"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.2337\/db06-0080","article-title":"Paradoxical stimulation of glucagon secretion by high glucose concentrations","volume":"55","author":"Salehi","year":"2006","journal-title":"Diabetes"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2337\/db21-0024","article-title":"Glucagon Clearance Is Preserved in Type 2 Diabetes","volume":"71","author":"Lund","year":"2022","journal-title":"Diabetes"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1053\/meta.2002.34700","article-title":"Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals","volume":"51","author":"Matsuda","year":"2002","journal-title":"Metabolism"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","article-title":"Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction","volume":"6","author":"Michael","year":"2000","journal-title":"Mol. Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/dc11-2010","article-title":"Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes","volume":"35","author":"Siafarikas","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Bisgaard Bengtsen, M., and Moller, N. (2021). Mini-review: Glucagon responses in type 1 diabetes\u2014A matter of complexity. Physiol. Rep., 9.","DOI":"10.14814\/phy2.15009"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/jdi.13486","article-title":"Impact of glucagon response on early postprandial glucose excursions irrespective of residual beta-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance test","volume":"12","author":"Ito","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Zhang, L., Qin, Y., Huang, Y., Hu, Q., Wu, Q., Wang, X., and Zhang, M. (2024). Abnormal late postprandial glucagon response in type 1 diabetes is a function of differences in stimulated C-peptide concentrations. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1419329"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1256S","DOI":"10.1093\/ajcn\/71.5.1256s","article-title":"Carbohydrate and lipid metabolism in pregnancy: Normal compared with gestational diabetes mellitus","volume":"71","author":"Butte","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_154","first-page":"CC01","article-title":"Normal pregnancy- a state of insulin resistance","volume":"8","author":"Sonagra","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Napso, T., Yong, H.E.J., Lopez-Tello, J., and Sferruzzi-Perri, A.N. (2018). The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.01091"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Kampmann, U., Knorr, S., Fuglsang, J., and Ovesen, P. (2019). Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview. J. Diabetes Res., 2019.","DOI":"10.1155\/2019\/5320156"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Piro, A.L., Dai, F.F., and Wheeler, M.B. (2022). Adaptive Changes in Glucose Homeostasis and Islet Function During Pregnancy: A Targeted Metabolomics Study in Mice. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.852149"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/dom.12716","article-title":"beta-Cell adaptation in pregnancy","volume":"18","author":"Baeyens","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1210\/jc.2003-030726","article-title":"Human Placental Growth Hormone, Insulin-Like Growth Factor I and -II, and Insulin Requirements during Pregnancy in Type 1 Diabetes","volume":"88","author":"Fuglsang","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbrc.2006.12.134","article-title":"Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release","volume":"353","author":"Nakata","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12944-019-1169-2","article-title":"Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus","volume":"18","author":"Bawah","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"10","DOI":"10.17925\/EE.2024.20.1.5","article-title":"The Placental Role in Gestational Diabetes Mellitus: A Molecular Perspective","volume":"20","author":"Calvo","year":"2024","journal-title":"touchREV Endocrinol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Zgutka, K., Tkacz, M., Tomasiak, P., Piotrowska, K., Ustianowski, P., Pawlik, A., and Tarnowski, M. (2024). Gestational Diabetes Mellitus-Induced Inflammation in the Placenta via IL-1beta and Toll-like Receptor Pathways. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111409"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc11-1409","article-title":"Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: The SWIFT cohort","volume":"35","author":"Gunderson","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Lai, M., Al Rijjal, D., Rost, H.L., Dai, F.F., Gunderson, E.P., and Wheeler, M.B. (2020). Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes. eLife, 9.","DOI":"10.7554\/eLife.59153"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Eades, C.E., Styles, M., Leese, G.P., Cheyne, H., and Evans, J.M. (2015). Progression from gestational diabetes to type 2 diabetes in one region of Scotland: An observational follow-up study. BMC Pregnancy Childbirth, 15.","DOI":"10.1186\/s12884-015-0457-8"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4093\/dmj.2022.0348","article-title":"Gestational Diabetes Mellitus and Its Implications across the Life Span","volume":"47","author":"Wicklow","year":"2023","journal-title":"Diabetes Metab. J."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Wang, Z., Yuan, M., Xu, C., Zhang, Y., Ying, C., and Xiao, X. (2021). FGF21 Serum Levels in the Early Second Trimester Are Positively Correlated with the Risk of Subsequent Gestational Diabetes Mellitus: A Propensity-Matched Nested Case-Control Study. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.630287"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Jin, C., Lin, L., Han, N., Zhao, Z., Liu, Z., Luo, S., Xu, X., Liu, J., and Wang, H. (2020). Effects of dynamic change in fetuin-A levels from the first to the second trimester on insulin resistance and gestational diabetes mellitus: A nested case-control study. BMJ Open Diabetes Res. Care, 8.","DOI":"10.1136\/bmjdrc-2019-000802"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Gaal, Z., Szucs, Z., Kantor, I., Luczay, A., Toth-Heyn, P., Benn, O., Felszeghy, E., Karadi, Z., Madar, L., and Balogh, I. (2021). A Comprehensive Analysis of Hungarian MODY Patients-Part II: Glucokinase MODY Is the Most Prevalent Subtype Responsible for about 70% of Confirmed Cases. Life, 11.","DOI":"10.3390\/life11080771"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s11658-024-00640-3","article-title":"Glucokinase (GCK) in diabetes: From molecular mechanisms to disease pathogenesis","volume":"29","author":"Alnesf","year":"2024","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1074\/jbc.M010523200","article-title":"A Molecular Link between the Common Phenotypes of Type 1 Glycogen Storage Disease and HNF1\u03b1-null Mice","volume":"276","author":"Hiraiwa","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/jhg.2011.106","article-title":"Single-nucleotide polymorphisms at five loci are associated with C-reactive protein levels in a cohort of Filipino young adults","volume":"56","author":"Curocichin","year":"2011","journal-title":"J. Hum. Genet."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.isci.2019.05.032","article-title":"HNF4A Haploinsufficiency in MODY1 Abrogates Liver and Pancreas Differentiation from Patient-Derived Induced Pluripotent Stem Cells","volume":"16","author":"Ng","year":"2019","journal-title":"iScience"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1038\/s41467-024-48647-w","article-title":"HNF4A and HNF1A exhibit tissue specific target gene regulation in pancreatic beta cells and hepatocytes","volume":"15","author":"Ng","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Ebrahim, N., Shakirova, K., and Dashinimaev, E. (2022). PDX1 is the cornerstone of pancreatic beta-cell functions and identity. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.1091757"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/humu.23995","article-title":"Update of variants identified in the pancreatic beta-cell K(ATP) channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes","volume":"41","author":"Brusgaard","year":"2020","journal-title":"Hum. Mutat."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.tem.2010.07.001","article-title":"Proinsulin misfolding and diabetes: Mutant INS gene-induced diabetes of youth","volume":"21","author":"Liu","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/db13-0717","article-title":"beta-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome","volume":"63","author":"Shang","year":"2014","journal-title":"Diabetes"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajpath.2024.02.005","article-title":"Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion","volume":"194","author":"Newberry","year":"2024","journal-title":"Am. J. Pathol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Ceccarini, G., Magno, S., Pelosini, C., Ferrari, F., Sessa, M.R., Scabia, G., Maffei, M., Jeru, I., Lascols, O., and Vigouroux, C. (2020). Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel AGPAT2 Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00039"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/19491034.2018.1456217","article-title":"Lipodystrophic syndromes due to LMNA mutations: Recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives","volume":"9","author":"Vigouroux","year":"2018","journal-title":"Nucleus"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Cao, L., An, Y., Liu, H., Jiang, J., Liu, W., Zhou, Y., Shi, M., Dai, W., Lv, Y., and Zhao, Y. (2024). Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: A systematic review and meta-analysis. BMC Med., 22.","DOI":"10.1186\/s12916-024-03315-0"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People with Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5152\/tjg.2021.201165","article-title":"Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease","volume":"33","author":"Karamfilova","year":"2022","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1210\/en.2010-0176","article-title":"Caloric restriction reverses hepatic insulin resistance and steatosis in rats with low aerobic capacity","volume":"151","author":"Bowman","year":"2010","journal-title":"Endocrinology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/oby.2008.201","article-title":"Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function","volume":"16","author":"Newcomer","year":"2008","journal-title":"Obesity"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"101675","DOI":"10.1016\/j.molmet.2023.101675","article-title":"A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice","volume":"69","author":"Long","year":"2023","journal-title":"Mol. Metab."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.3390\/nu7115454","article-title":"Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance","volume":"7","year":"2015","journal-title":"Nutrients"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Gong, Y., Zhang, H., Feng, J., Ying, L., Ji, M., Wei, S., and Ma, Q. (2025). Time-restricted feeding improves metabolic syndrome by activating thermogenesis in brown adipose tissue and reducing inflammatory markers. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1501850"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"E749","DOI":"10.1152\/ajpendo.00178.2016","article-title":"Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis","volume":"311","author":"Morris","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nutres.2024.04.002","article-title":"Exercise enhances hepatic mitochondrial structure and function while preventing endoplasmic reticulum stress and metabolic dysfunction-associated steatotic liver disease in mice fed a high-fat diet","volume":"126","year":"2024","journal-title":"Nutr. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","article-title":"Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over","volume":"6","author":"Ryan","year":"2017","journal-title":"Curr. Obes. Rep."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.soard.2023.07.005","article-title":"The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis","volume":"19","author":"Poljo","year":"2023","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Cerreto, M., Santopaolo, F., Gasbarrini, A., Pompili, M., and Ponziani, F.R. (2021). Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut-Liver Axis. Nutrients, 13.","DOI":"10.3390\/nu13082649"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Szymczak-Pajor, I., Wenclewska, S., and Sliwinska, A. (2022). Metabolic Action of Metformin. Pharmaceuticals, 15.","DOI":"10.3390\/ph15070810"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Huang, H., Lorenz, B.R., Zelmanovitz, P.H., and Chan, C.B. (2021). Metformin Preserves beta-Cell Compensation in Insulin Secretion and Mass Expansion in Prediabetic Nile Rats. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010421"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Shyr, Z.A., Yan, Z., Ustione, A., Egan, E.M., and Remedi, M.S. (2022). SGLT2 inhibitors therapy protects glucotoxicity-induced beta-cell failure in a mouse model of human KATP-induced diabetes through mitigation of oxidative and ER stress. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0258054"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Osataphan, S., Macchi, C., Singhal, G., Chimene-Weiss, J., Sales, V., Kozuka, C., Dreyfuss, J.M., Pan, H., Tangcharoenpaisan, Y., and Morningstar, J. (2019). SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms. JCI Insight, 4.","DOI":"10.1172\/jci.insight.123130"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/endrev\/bnac018","article-title":"Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease","volume":"44","author":"Yabut","year":"2023","journal-title":"Endocr. Rev."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2010.09.032","article-title":"Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase","volume":"54","author":"Zvibel","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1038\/s41467-025-59773-4","article-title":"GLP-1R\/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic beta-cell function in obese male mice","volume":"16","author":"Laker","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmet.2022.07.013","article-title":"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept","volume":"34","author":"Coskun","year":"2022","journal-title":"Cell Metab."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: A randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat. Med."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2337\/db11-0838","article-title":"FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents","volume":"61","author":"Mu","year":"2012","journal-title":"Diabetes"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"103202","DOI":"10.1016\/j.ebiom.2020.103202","article-title":"A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis","volume":"63","author":"Pan","year":"2021","journal-title":"eBioMedicine"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Kim, B., Ronaldo, R., Kweon, B.N., Yoon, S., Park, Y., Baek, J.H., Lee, J.M., and Hyun, C.K. (2024). Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin Axis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910447"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13287-020-01610-0","article-title":"Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation","volume":"11","author":"Chen","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_213","first-page":"576","article-title":"Multi-omics profiling: The way towards precision medicine in metabolic diseases","volume":"13","author":"Hu","year":"2021","journal-title":"J. Mol. Cell Biol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Lai, M., Liu, Y., Ronnett, G.V., Wu, A., Cox, B.J., Dai, F.F., Rost, H.L., Gunderson, E.P., and Wheeler, M.B. (2020). Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003112"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Lai, M., Piro, A.L., Alexeeff, S.E., Allalou, A., Rost, H.L., Dai, F.F., Wheeler, M.B., and Gunderson, E.P. (2021). Intensive lactation among women with recent gestational diabetes significantly alters the early postpartum circulating lipid profile: The SWIFT study. BMC Med., 19.","DOI":"10.1186\/s12916-021-02095-1"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2337\/db15-1720","article-title":"A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes","volume":"65","author":"Allalou","year":"2016","journal-title":"Diabetes"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41597-025-05450-6","article-title":"A spatial transcriptomics dataset of pancreas sections in normal glucose tolerance and type 2 diabetic donors","volume":"12","author":"Howell","year":"2025","journal-title":"Sci. Data"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1038\/s41467-024-53659-7","article-title":"Alternations in inflammatory macrophage niche drive phenotypic and functional plasticity of Kupffer cells","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1038\/s41467-023-41228-3","article-title":"Single cell multiomic analysis reveals diabetes-associated beta-cell heterogeneity driven by HNF1A","volume":"14","author":"Weng","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic beta cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/scd.2024.0067","article-title":"Mice Hepatic Organoids for Modeling Nonalcoholic Fatty Liver Disease and Drug Response","volume":"33","author":"Zhou","year":"2024","journal-title":"Stem Cells Dev."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbrc.2016.08.104","article-title":"Study on AAV-mediated gene therapy for diabetes in humanized liver mouse to predict efficacy in humans","volume":"478","author":"Hashimoto","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/4\/613\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:26:18Z","timestamp":1776918378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/4\/613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":223,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["biom16040613"],"URL":"https:\/\/doi.org\/10.3390\/biom16040613","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}